Global Recombinant Protein Drug R&D Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Recombinant Protein Drug R&D will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Protein Drug R&D market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Protein Drug R&D market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Recombinant Protein Drug R&D market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Protein Drug R&D market, reaching US$ million by the year 2028. As for the Europe Recombinant Protein Drug R&D landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Protein Drug R&D players cover Eli Lilly, Novo Nordisk, Amgen, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Drug R&D market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Recombinant Protein Drug R&D will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Protein Drug R&D market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Protein Drug R&D market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Recombinant Protein Drug R&D market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Protein Drug R&D market, reaching US$ million by the year 2028. As for the Europe Recombinant Protein Drug R&D landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Recombinant Protein Drug R&D players cover Eli Lilly, Novo Nordisk, Amgen, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Drug R&D market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Peptide Hormones
- Hematopoietic Factor
- Cytokines
- Plasma Protein Factor
- Recombinase
- Fusion Protein
- Other
- Diabetes
- Dwarfism
- Hemophilia
- Heart Disease
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Novo Nordisk
- Amgen
- Merck
- Sanofi
- Pfizer
- Roche
- Gensci
- Ankebio
- United Cell
- Sinobioway Hygene
- Kexing
- Dongbao
- 3sbio
- Gan&Lee
- Hengrui
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Protein Drug R&D Market Size 2017-2028
2.1.2 Recombinant Protein Drug R&D Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Recombinant Protein Drug R&D Segment by Type
2.2.1 Peptide Hormones
2.2.2 Hematopoietic Factor
2.2.3 Cytokines
2.2.4 Plasma Protein Factor
2.2.5 Recombinase
2.2.6 Fusion Protein
2.2.7 Other
2.3 Recombinant Protein Drug R&D Market Size by Type
2.3.1 Recombinant Protein Drug R&D Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
2.4 Recombinant Protein Drug R&D Segment by Application
2.4.1 Diabetes
2.4.2 Dwarfism
2.4.3 Hemophilia
2.4.4 Heart Disease
2.4.5 Cancer
2.4.6 Other
2.5 Recombinant Protein Drug R&D Market Size by Application
2.5.1 Recombinant Protein Drug R&D Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
3 RECOMBINANT PROTEIN DRUG R&D MARKET SIZE BY PLAYER
3.1 Recombinant Protein Drug R&D Market Size Market Share by Players
3.1.1 Global Recombinant Protein Drug R&D Revenue by Players (2020-2022)
3.1.2 Global Recombinant Protein Drug R&D Revenue Market Share by Players (2020-2022)
3.2 Global Recombinant Protein Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT PROTEIN DRUG R&D BY REGIONS
4.1 Recombinant Protein Drug R&D Market Size by Regions (2017-2022)
4.2 Americas Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.3 APAC Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.4 Europe Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.5 Middle East & Africa Recombinant Protein Drug R&D Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Recombinant Protein Drug R&D Market Size by Country (2017-2022)
5.2 Americas Recombinant Protein Drug R&D Market Size by Type (2017-2022)
5.3 Americas Recombinant Protein Drug R&D Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Drug R&D Market Size by Region (2017-2022)
6.2 APAC Recombinant Protein Drug R&D Market Size by Type (2017-2022)
6.3 APAC Recombinant Protein Drug R&D Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant Protein Drug R&D by Country (2017-2022)
7.2 Europe Recombinant Protein Drug R&D Market Size by Type (2017-2022)
7.3 Europe Recombinant Protein Drug R&D Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Protein Drug R&D by Region (2017-2022)
8.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2017-2022)
8.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT PROTEIN DRUG R&D MARKET FORECAST
10.1 Global Recombinant Protein Drug R&D Forecast by Regions (2023-2028)
10.1.1 Global Recombinant Protein Drug R&D Forecast by Regions (2023-2028)
10.1.2 Americas Recombinant Protein Drug R&D Forecast
10.1.3 APAC Recombinant Protein Drug R&D Forecast
10.1.4 Europe Recombinant Protein Drug R&D Forecast
10.1.5 Middle East & Africa Recombinant Protein Drug R&D Forecast
10.2 Americas Recombinant Protein Drug R&D Forecast by Country (2023-2028)
10.2.1 United States Recombinant Protein Drug R&D Market Forecast
10.2.2 Canada Recombinant Protein Drug R&D Market Forecast
10.2.3 Mexico Recombinant Protein Drug R&D Market Forecast
10.2.4 Brazil Recombinant Protein Drug R&D Market Forecast
10.3 APAC Recombinant Protein Drug R&D Forecast by Region (2023-2028)
10.3.1 China Recombinant Protein Drug R&D Market Forecast
10.3.2 Japan Recombinant Protein Drug R&D Market Forecast
10.3.3 Korea Recombinant Protein Drug R&D Market Forecast
10.3.4 Southeast Asia Recombinant Protein Drug R&D Market Forecast
10.3.5 India Recombinant Protein Drug R&D Market Forecast
10.3.6 Australia Recombinant Protein Drug R&D Market Forecast
10.4 Europe Recombinant Protein Drug R&D Forecast by Country (2023-2028)
10.4.1 Germany Recombinant Protein Drug R&D Market Forecast
10.4.2 France Recombinant Protein Drug R&D Market Forecast
10.4.3 UK Recombinant Protein Drug R&D Market Forecast
10.4.4 Italy Recombinant Protein Drug R&D Market Forecast
10.4.5 Russia Recombinant Protein Drug R&D Market Forecast
10.5 Middle East & Africa Recombinant Protein Drug R&D Forecast by Region (2023-2028)
10.5.1 Egypt Recombinant Protein Drug R&D Market Forecast
10.5.2 South Africa Recombinant Protein Drug R&D Market Forecast
10.5.3 Israel Recombinant Protein Drug R&D Market Forecast
10.5.4 Turkey Recombinant Protein Drug R&D Market Forecast
10.5.5 GCC Countries Recombinant Protein Drug R&D Market Forecast
10.6 Global Recombinant Protein Drug R&D Forecast by Type (2023-2028)
10.7 Global Recombinant Protein Drug R&D Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Recombinant Protein Drug R&D Product Offered
11.1.3 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Eli Lilly Main Business Overview
11.1.5 Eli Lilly Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Recombinant Protein Drug R&D Product Offered
11.2.3 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Recombinant Protein Drug R&D Product Offered
11.3.3 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Recombinant Protein Drug R&D Product Offered
11.4.3 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Recombinant Protein Drug R&D Product Offered
11.5.3 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Recombinant Protein Drug R&D Product Offered
11.6.3 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Recombinant Protein Drug R&D Product Offered
11.7.3 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Gensci
11.8.1 Gensci Company Information
11.8.2 Gensci Recombinant Protein Drug R&D Product Offered
11.8.3 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Gensci Main Business Overview
11.8.5 Gensci Latest Developments
11.9 Ankebio
11.9.1 Ankebio Company Information
11.9.2 Ankebio Recombinant Protein Drug R&D Product Offered
11.9.3 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ankebio Main Business Overview
11.9.5 Ankebio Latest Developments
11.10 United Cell
11.10.1 United Cell Company Information
11.10.2 United Cell Recombinant Protein Drug R&D Product Offered
11.10.3 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 United Cell Main Business Overview
11.10.5 United Cell Latest Developments
11.11 Sinobioway Hygene
11.11.1 Sinobioway Hygene Company Information
11.11.2 Sinobioway Hygene Recombinant Protein Drug R&D Product Offered
11.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sinobioway Hygene Main Business Overview
11.11.5 Sinobioway Hygene Latest Developments
11.12 Kexing
11.12.1 Kexing Company Information
11.12.2 Kexing Recombinant Protein Drug R&D Product Offered
11.12.3 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Kexing Main Business Overview
11.12.5 Kexing Latest Developments
11.13 Dongbao
11.13.1 Dongbao Company Information
11.13.2 Dongbao Recombinant Protein Drug R&D Product Offered
11.13.3 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Dongbao Main Business Overview
11.13.5 Dongbao Latest Developments
11.14 3sbio
11.14.1 3sbio Company Information
11.14.2 3sbio Recombinant Protein Drug R&D Product Offered
11.14.3 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 3sbio Main Business Overview
11.14.5 3sbio Latest Developments
11.15 Gan&Lee
11.15.1 Gan&Lee Company Information
11.15.2 Gan&Lee Recombinant Protein Drug R&D Product Offered
11.15.3 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Gan&Lee Main Business Overview
11.15.5 Gan&Lee Latest Developments
11.16 Hengrui
11.16.1 Hengrui Company Information
11.16.2 Hengrui Recombinant Protein Drug R&D Product Offered
11.16.3 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Hengrui Main Business Overview
11.16.5 Hengrui Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Protein Drug R&D Market Size 2017-2028
2.1.2 Recombinant Protein Drug R&D Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Recombinant Protein Drug R&D Segment by Type
2.2.1 Peptide Hormones
2.2.2 Hematopoietic Factor
2.2.3 Cytokines
2.2.4 Plasma Protein Factor
2.2.5 Recombinase
2.2.6 Fusion Protein
2.2.7 Other
2.3 Recombinant Protein Drug R&D Market Size by Type
2.3.1 Recombinant Protein Drug R&D Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
2.4 Recombinant Protein Drug R&D Segment by Application
2.4.1 Diabetes
2.4.2 Dwarfism
2.4.3 Hemophilia
2.4.4 Heart Disease
2.4.5 Cancer
2.4.6 Other
2.5 Recombinant Protein Drug R&D Market Size by Application
2.5.1 Recombinant Protein Drug R&D Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
3 RECOMBINANT PROTEIN DRUG R&D MARKET SIZE BY PLAYER
3.1 Recombinant Protein Drug R&D Market Size Market Share by Players
3.1.1 Global Recombinant Protein Drug R&D Revenue by Players (2020-2022)
3.1.2 Global Recombinant Protein Drug R&D Revenue Market Share by Players (2020-2022)
3.2 Global Recombinant Protein Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT PROTEIN DRUG R&D BY REGIONS
4.1 Recombinant Protein Drug R&D Market Size by Regions (2017-2022)
4.2 Americas Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.3 APAC Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.4 Europe Recombinant Protein Drug R&D Market Size Growth (2017-2022)
4.5 Middle East & Africa Recombinant Protein Drug R&D Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Recombinant Protein Drug R&D Market Size by Country (2017-2022)
5.2 Americas Recombinant Protein Drug R&D Market Size by Type (2017-2022)
5.3 Americas Recombinant Protein Drug R&D Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Drug R&D Market Size by Region (2017-2022)
6.2 APAC Recombinant Protein Drug R&D Market Size by Type (2017-2022)
6.3 APAC Recombinant Protein Drug R&D Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant Protein Drug R&D by Country (2017-2022)
7.2 Europe Recombinant Protein Drug R&D Market Size by Type (2017-2022)
7.3 Europe Recombinant Protein Drug R&D Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Protein Drug R&D by Region (2017-2022)
8.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2017-2022)
8.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT PROTEIN DRUG R&D MARKET FORECAST
10.1 Global Recombinant Protein Drug R&D Forecast by Regions (2023-2028)
10.1.1 Global Recombinant Protein Drug R&D Forecast by Regions (2023-2028)
10.1.2 Americas Recombinant Protein Drug R&D Forecast
10.1.3 APAC Recombinant Protein Drug R&D Forecast
10.1.4 Europe Recombinant Protein Drug R&D Forecast
10.1.5 Middle East & Africa Recombinant Protein Drug R&D Forecast
10.2 Americas Recombinant Protein Drug R&D Forecast by Country (2023-2028)
10.2.1 United States Recombinant Protein Drug R&D Market Forecast
10.2.2 Canada Recombinant Protein Drug R&D Market Forecast
10.2.3 Mexico Recombinant Protein Drug R&D Market Forecast
10.2.4 Brazil Recombinant Protein Drug R&D Market Forecast
10.3 APAC Recombinant Protein Drug R&D Forecast by Region (2023-2028)
10.3.1 China Recombinant Protein Drug R&D Market Forecast
10.3.2 Japan Recombinant Protein Drug R&D Market Forecast
10.3.3 Korea Recombinant Protein Drug R&D Market Forecast
10.3.4 Southeast Asia Recombinant Protein Drug R&D Market Forecast
10.3.5 India Recombinant Protein Drug R&D Market Forecast
10.3.6 Australia Recombinant Protein Drug R&D Market Forecast
10.4 Europe Recombinant Protein Drug R&D Forecast by Country (2023-2028)
10.4.1 Germany Recombinant Protein Drug R&D Market Forecast
10.4.2 France Recombinant Protein Drug R&D Market Forecast
10.4.3 UK Recombinant Protein Drug R&D Market Forecast
10.4.4 Italy Recombinant Protein Drug R&D Market Forecast
10.4.5 Russia Recombinant Protein Drug R&D Market Forecast
10.5 Middle East & Africa Recombinant Protein Drug R&D Forecast by Region (2023-2028)
10.5.1 Egypt Recombinant Protein Drug R&D Market Forecast
10.5.2 South Africa Recombinant Protein Drug R&D Market Forecast
10.5.3 Israel Recombinant Protein Drug R&D Market Forecast
10.5.4 Turkey Recombinant Protein Drug R&D Market Forecast
10.5.5 GCC Countries Recombinant Protein Drug R&D Market Forecast
10.6 Global Recombinant Protein Drug R&D Forecast by Type (2023-2028)
10.7 Global Recombinant Protein Drug R&D Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Recombinant Protein Drug R&D Product Offered
11.1.3 Eli Lilly Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Eli Lilly Main Business Overview
11.1.5 Eli Lilly Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Recombinant Protein Drug R&D Product Offered
11.2.3 Novo Nordisk Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Recombinant Protein Drug R&D Product Offered
11.3.3 Amgen Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Recombinant Protein Drug R&D Product Offered
11.4.3 Merck Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Recombinant Protein Drug R&D Product Offered
11.5.3 Sanofi Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Recombinant Protein Drug R&D Product Offered
11.6.3 Pfizer Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Recombinant Protein Drug R&D Product Offered
11.7.3 Roche Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Gensci
11.8.1 Gensci Company Information
11.8.2 Gensci Recombinant Protein Drug R&D Product Offered
11.8.3 Gensci Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Gensci Main Business Overview
11.8.5 Gensci Latest Developments
11.9 Ankebio
11.9.1 Ankebio Company Information
11.9.2 Ankebio Recombinant Protein Drug R&D Product Offered
11.9.3 Ankebio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ankebio Main Business Overview
11.9.5 Ankebio Latest Developments
11.10 United Cell
11.10.1 United Cell Company Information
11.10.2 United Cell Recombinant Protein Drug R&D Product Offered
11.10.3 United Cell Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 United Cell Main Business Overview
11.10.5 United Cell Latest Developments
11.11 Sinobioway Hygene
11.11.1 Sinobioway Hygene Company Information
11.11.2 Sinobioway Hygene Recombinant Protein Drug R&D Product Offered
11.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sinobioway Hygene Main Business Overview
11.11.5 Sinobioway Hygene Latest Developments
11.12 Kexing
11.12.1 Kexing Company Information
11.12.2 Kexing Recombinant Protein Drug R&D Product Offered
11.12.3 Kexing Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Kexing Main Business Overview
11.12.5 Kexing Latest Developments
11.13 Dongbao
11.13.1 Dongbao Company Information
11.13.2 Dongbao Recombinant Protein Drug R&D Product Offered
11.13.3 Dongbao Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Dongbao Main Business Overview
11.13.5 Dongbao Latest Developments
11.14 3sbio
11.14.1 3sbio Company Information
11.14.2 3sbio Recombinant Protein Drug R&D Product Offered
11.14.3 3sbio Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 3sbio Main Business Overview
11.14.5 3sbio Latest Developments
11.15 Gan&Lee
11.15.1 Gan&Lee Company Information
11.15.2 Gan&Lee Recombinant Protein Drug R&D Product Offered
11.15.3 Gan&Lee Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Gan&Lee Main Business Overview
11.15.5 Gan&Lee Latest Developments
11.16 Hengrui
11.16.1 Hengrui Company Information
11.16.2 Hengrui Recombinant Protein Drug R&D Product Offered
11.16.3 Hengrui Recombinant Protein Drug R&D Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Hengrui Main Business Overview
11.16.5 Hengrui Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Protein Drug R&D Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peptide Hormones
Table 3. Major Players of Hematopoietic Factor
Table 4. Major Players of Cytokines
Table 5. Major Players of Plasma Protein Factor
Table 6. Major Players of Recombinase
Table 7. Major Players of Fusion Protein
Table 8. Major Players of Other
Table 9. Recombinant Protein Drug R&D Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 12. Recombinant Protein Drug R&D Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 15. Global Recombinant Protein Drug R&D Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Recombinant Protein Drug R&D Revenue Market Share by Player (2020-2022)
Table 17. Recombinant Protein Drug R&D Key Players Head office and Products Offered
Table 18. Recombinant Protein Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Recombinant Protein Drug R&D Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Recombinant Protein Drug R&D Market Size Market Share by Regions (2017-2022)
Table 23. Americas Recombinant Protein Drug R&D Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Recombinant Protein Drug R&D Market Size Market Share by Country (2017-2022)
Table 25. Americas Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 27. Americas Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 29. APAC Recombinant Protein Drug R&D Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Recombinant Protein Drug R&D Market Size Market Share by Region (2017-2022)
Table 31. APAC Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 33. APAC Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 35. Europe Recombinant Protein Drug R&D Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Recombinant Protein Drug R&D Market Size Market Share by Country (2017-2022)
Table 37. Europe Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 39. Europe Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Recombinant Protein Drug R&D Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Recombinant Protein Drug R&D
Table 48. Key Market Challenges & Risks of Recombinant Protein Drug R&D
Table 49. Key Industry Trends of Recombinant Protein Drug R&D
Table 50. Global Recombinant Protein Drug R&D Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Recombinant Protein Drug R&D Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Recombinant Protein Drug R&D Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Application (2023-2028)
Table 56. Eli Lilly Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 57. Eli Lilly Recombinant Protein Drug R&D Product Offered
Table 58. Eli Lilly Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Eli Lilly Main Business
Table 60. Eli Lilly Latest Developments
Table 61. Novo Nordisk Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 62. Novo Nordisk Recombinant Protein Drug R&D Product Offered
Table 63. Novo Nordisk Main Business
Table 64. Novo Nordisk Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novo Nordisk Latest Developments
Table 66. Amgen Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 67. Amgen Recombinant Protein Drug R&D Product Offered
Table 68. Amgen Main Business
Table 69. Amgen Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Amgen Latest Developments
Table 71. Merck Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 72. Merck Recombinant Protein Drug R&D Product Offered
Table 73. Merck Main Business
Table 74. Merck Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Merck Latest Developments
Table 76. Sanofi Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 77. Sanofi Recombinant Protein Drug R&D Product Offered
Table 78. Sanofi Main Business
Table 79. Sanofi Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sanofi Latest Developments
Table 81. Pfizer Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 82. Pfizer Recombinant Protein Drug R&D Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer Latest Developments
Table 86. Roche Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 87. Roche Recombinant Protein Drug R&D Product Offered
Table 88. Roche Main Business
Table 89. Roche Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche Latest Developments
Table 91. Gensci Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 92. Gensci Recombinant Protein Drug R&D Product Offered
Table 93. Gensci Main Business
Table 94. Gensci Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Gensci Latest Developments
Table 96. Ankebio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 97. Ankebio Recombinant Protein Drug R&D Product Offered
Table 98. Ankebio Main Business
Table 99. Ankebio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Ankebio Latest Developments
Table 101. United Cell Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 102. United Cell Recombinant Protein Drug R&D Product Offered
Table 103. United Cell Main Business
Table 104. United Cell Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. United Cell Latest Developments
Table 106. Sinobioway Hygene Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 107. Sinobioway Hygene Recombinant Protein Drug R&D Product Offered
Table 108. Sinobioway Hygene Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Sinobioway Hygene Main Business
Table 110. Sinobioway Hygene Latest Developments
Table 111. Kexing Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 112. Kexing Recombinant Protein Drug R&D Product Offered
Table 113. Kexing Main Business
Table 114. Kexing Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Kexing Latest Developments
Table 116. Dongbao Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 117. Dongbao Recombinant Protein Drug R&D Product Offered
Table 118. Dongbao Main Business
Table 119. Dongbao Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Dongbao Latest Developments
Table 121. 3sbio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 122. 3sbio Recombinant Protein Drug R&D Product Offered
Table 123. 3sbio Main Business
Table 124. 3sbio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. 3sbio Latest Developments
Table 126. Gan&Lee Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 127. Gan&Lee Recombinant Protein Drug R&D Product Offered
Table 128. Gan&Lee Main Business
Table 129. Gan&Lee Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Gan&Lee Latest Developments
Table 131. Hengrui Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 132. Hengrui Recombinant Protein Drug R&D Product Offered
Table 133. Hengrui Main Business
Table 134. Hengrui Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Hengrui Latest Developments
Table 1. Recombinant Protein Drug R&D Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Peptide Hormones
Table 3. Major Players of Hematopoietic Factor
Table 4. Major Players of Cytokines
Table 5. Major Players of Plasma Protein Factor
Table 6. Major Players of Recombinase
Table 7. Major Players of Fusion Protein
Table 8. Major Players of Other
Table 9. Recombinant Protein Drug R&D Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 12. Recombinant Protein Drug R&D Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 15. Global Recombinant Protein Drug R&D Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Recombinant Protein Drug R&D Revenue Market Share by Player (2020-2022)
Table 17. Recombinant Protein Drug R&D Key Players Head office and Products Offered
Table 18. Recombinant Protein Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Recombinant Protein Drug R&D Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Recombinant Protein Drug R&D Market Size Market Share by Regions (2017-2022)
Table 23. Americas Recombinant Protein Drug R&D Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Recombinant Protein Drug R&D Market Size Market Share by Country (2017-2022)
Table 25. Americas Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 27. Americas Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 29. APAC Recombinant Protein Drug R&D Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Recombinant Protein Drug R&D Market Size Market Share by Region (2017-2022)
Table 31. APAC Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 33. APAC Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 35. Europe Recombinant Protein Drug R&D Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Recombinant Protein Drug R&D Market Size Market Share by Country (2017-2022)
Table 37. Europe Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 39. Europe Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Recombinant Protein Drug R&D Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Recombinant Protein Drug R&D
Table 48. Key Market Challenges & Risks of Recombinant Protein Drug R&D
Table 49. Key Industry Trends of Recombinant Protein Drug R&D
Table 50. Global Recombinant Protein Drug R&D Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Recombinant Protein Drug R&D Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Recombinant Protein Drug R&D Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Recombinant Protein Drug R&D Market Size Market Share Forecast by Application (2023-2028)
Table 56. Eli Lilly Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 57. Eli Lilly Recombinant Protein Drug R&D Product Offered
Table 58. Eli Lilly Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Eli Lilly Main Business
Table 60. Eli Lilly Latest Developments
Table 61. Novo Nordisk Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 62. Novo Nordisk Recombinant Protein Drug R&D Product Offered
Table 63. Novo Nordisk Main Business
Table 64. Novo Nordisk Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novo Nordisk Latest Developments
Table 66. Amgen Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 67. Amgen Recombinant Protein Drug R&D Product Offered
Table 68. Amgen Main Business
Table 69. Amgen Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Amgen Latest Developments
Table 71. Merck Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 72. Merck Recombinant Protein Drug R&D Product Offered
Table 73. Merck Main Business
Table 74. Merck Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Merck Latest Developments
Table 76. Sanofi Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 77. Sanofi Recombinant Protein Drug R&D Product Offered
Table 78. Sanofi Main Business
Table 79. Sanofi Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sanofi Latest Developments
Table 81. Pfizer Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 82. Pfizer Recombinant Protein Drug R&D Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Pfizer Latest Developments
Table 86. Roche Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 87. Roche Recombinant Protein Drug R&D Product Offered
Table 88. Roche Main Business
Table 89. Roche Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche Latest Developments
Table 91. Gensci Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 92. Gensci Recombinant Protein Drug R&D Product Offered
Table 93. Gensci Main Business
Table 94. Gensci Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Gensci Latest Developments
Table 96. Ankebio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 97. Ankebio Recombinant Protein Drug R&D Product Offered
Table 98. Ankebio Main Business
Table 99. Ankebio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Ankebio Latest Developments
Table 101. United Cell Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 102. United Cell Recombinant Protein Drug R&D Product Offered
Table 103. United Cell Main Business
Table 104. United Cell Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. United Cell Latest Developments
Table 106. Sinobioway Hygene Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 107. Sinobioway Hygene Recombinant Protein Drug R&D Product Offered
Table 108. Sinobioway Hygene Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Sinobioway Hygene Main Business
Table 110. Sinobioway Hygene Latest Developments
Table 111. Kexing Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 112. Kexing Recombinant Protein Drug R&D Product Offered
Table 113. Kexing Main Business
Table 114. Kexing Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Kexing Latest Developments
Table 116. Dongbao Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 117. Dongbao Recombinant Protein Drug R&D Product Offered
Table 118. Dongbao Main Business
Table 119. Dongbao Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Dongbao Latest Developments
Table 121. 3sbio Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 122. 3sbio Recombinant Protein Drug R&D Product Offered
Table 123. 3sbio Main Business
Table 124. 3sbio Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. 3sbio Latest Developments
Table 126. Gan&Lee Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 127. Gan&Lee Recombinant Protein Drug R&D Product Offered
Table 128. Gan&Lee Main Business
Table 129. Gan&Lee Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Gan&Lee Latest Developments
Table 131. Hengrui Details, Company Type, Recombinant Protein Drug R&D Area Served and Its Competitors
Table 132. Hengrui Recombinant Protein Drug R&D Product Offered
Table 133. Hengrui Main Business
Table 134. Hengrui Recombinant Protein Drug R&D Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Hengrui Latest Developments
LIST OF FIGURES
Figure 1. Recombinant Protein Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Protein Drug R&D Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 7. Recombinant Protein Drug R&D in Diabetes
Figure 8. Global Recombinant Protein Drug R&D Market: Diabetes (2017-2022) & ($ Millions)
Figure 9. Recombinant Protein Drug R&D in Dwarfism
Figure 10. Global Recombinant Protein Drug R&D Market: Dwarfism (2017-2022) & ($ Millions)
Figure 11. Recombinant Protein Drug R&D in Hemophilia
Figure 12. Global Recombinant Protein Drug R&D Market: Hemophilia (2017-2022) & ($ Millions)
Figure 13. Recombinant Protein Drug R&D in Heart Disease
Figure 14. Global Recombinant Protein Drug R&D Market: Heart Disease (2017-2022) & ($ Millions)
Figure 15. Recombinant Protein Drug R&D in Cancer
Figure 16. Global Recombinant Protein Drug R&D Market: Cancer (2017-2022) & ($ Millions)
Figure 17. Recombinant Protein Drug R&D in Other
Figure 18. Global Recombinant Protein Drug R&D Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Player in 2021
Figure 21. Global Recombinant Protein Drug R&D Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 23. APAC Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 24. Europe Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 26. Americas Recombinant Protein Drug R&D Value Market Share by Country in 2021
Figure 27. Americas Recombinant Protein Drug R&D Consumption Market Share by Type in 2021
Figure 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 29. United States Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Recombinant Protein Drug R&D Market Size Market Share by Region in 2021
Figure 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 35. China Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Recombinant Protein Drug R&D Market Size Market Share by Country in 2021
Figure 42. Europe Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 43. Europe Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 44. Germany Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 52. Egypt Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 58. APAC Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 59. Europe Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 61. United States Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 62. Canada Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 65. China Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 66. Japan Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 67. Korea Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 69. India Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 70. Australia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 71. Germany Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 72. France Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 73. UK Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 74. Italy Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 75. Russia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 76. Spain Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 79. Israel Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 1. Recombinant Protein Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant Protein Drug R&D Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 7. Recombinant Protein Drug R&D in Diabetes
Figure 8. Global Recombinant Protein Drug R&D Market: Diabetes (2017-2022) & ($ Millions)
Figure 9. Recombinant Protein Drug R&D in Dwarfism
Figure 10. Global Recombinant Protein Drug R&D Market: Dwarfism (2017-2022) & ($ Millions)
Figure 11. Recombinant Protein Drug R&D in Hemophilia
Figure 12. Global Recombinant Protein Drug R&D Market: Hemophilia (2017-2022) & ($ Millions)
Figure 13. Recombinant Protein Drug R&D in Heart Disease
Figure 14. Global Recombinant Protein Drug R&D Market: Heart Disease (2017-2022) & ($ Millions)
Figure 15. Recombinant Protein Drug R&D in Cancer
Figure 16. Global Recombinant Protein Drug R&D Market: Cancer (2017-2022) & ($ Millions)
Figure 17. Recombinant Protein Drug R&D in Other
Figure 18. Global Recombinant Protein Drug R&D Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 20. Global Recombinant Protein Drug R&D Revenue Market Share by Player in 2021
Figure 21. Global Recombinant Protein Drug R&D Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 23. APAC Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 24. Europe Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Recombinant Protein Drug R&D Market Size 2017-2022 ($ Millions)
Figure 26. Americas Recombinant Protein Drug R&D Value Market Share by Country in 2021
Figure 27. Americas Recombinant Protein Drug R&D Consumption Market Share by Type in 2021
Figure 28. Americas Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 29. United States Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Recombinant Protein Drug R&D Market Size Market Share by Region in 2021
Figure 34. APAC Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 35. China Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Recombinant Protein Drug R&D Market Size Market Share by Country in 2021
Figure 42. Europe Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 43. Europe Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 44. Germany Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Recombinant Protein Drug R&D Market Size Market Share by Application in 2021
Figure 52. Egypt Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Recombinant Protein Drug R&D Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 58. APAC Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 59. Europe Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 61. United States Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 62. Canada Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 65. China Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 66. Japan Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 67. Korea Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 69. India Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 70. Australia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 71. Germany Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 72. France Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 73. UK Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 74. Italy Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 75. Russia Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 76. Spain Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 79. Israel Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Recombinant Protein Drug R&D Market Size 2023-2028 ($ Millions)
